The ability to deliver efficiently a complete genomic DNA locus to human and rodent cells will likely find widespread application in functional genomic studies and novel gene therapy protocols. In contrast to a cDNA expression cassette, the use of a complete genomic DNA locus delivers a transgene intact with its native promoter, the exons, all the intervening introns, and the regulatory regions. The presence of flanking, noncoding genomic DNA sequences could prove critical for prolonged and appropriate gene expression. We have recently developed a technology for the rapid conversion of bacterial artificial chromosome (BAC) clones into high-capacity herpes simplex virus-based amplicon vectors. Here, we express the human low-density lipoprote...
Acquiring sufficient amounts of high-quality cells remains an impediment to cell-based therapies. In...
We have isolated several non−leaky mutant Chinese hamster ovary (CHO) cell clones (M4, M19, and M21)...
International audienceBACKGROUND: The LDLR (low-density lipoprotein receptor) in the liver is the ma...
Familial hypercholesterolemia (FH) is a condition caused by mutations in the low-density lipoprotein...
Episomal gene expression vectors offer a safe and attractive alternative to integrating vectors. Her...
Background. Gene therapy of familial hypercholesterolemia (FH) requires successful transfer and life...
Familial hypercholesterolemia (FH) is a life-threatening genetic disorder characterized by elevated ...
BACKGROUND: The delivery of a complete genomic DNA locus in vivo may prove advantageous for compleme...
Familial hypercholesterolemia (FH) is a life-threatening genetic disorder characterised by elevated ...
The generation of functional transgenes via microinjection of overlapping dna fragments has previous...
Gene therapy for hypercholesterolemia offers the potential to sustainably ameliorate disease for lif...
The recent completion of the human genome sequence allows genomics research to focus on understandin...
The development of novel strategies to enhance gene expression from therapeutic vectors may prove ad...
Familial hypercholesterolemia (FH) is a genetic hyperlipidemia characterized by elevated concentrati...
We have isolated several non-leaky mutant Chinese hamster ovary (CHO) cell clones (M4, M19, and M21)...
Acquiring sufficient amounts of high-quality cells remains an impediment to cell-based therapies. In...
We have isolated several non−leaky mutant Chinese hamster ovary (CHO) cell clones (M4, M19, and M21)...
International audienceBACKGROUND: The LDLR (low-density lipoprotein receptor) in the liver is the ma...
Familial hypercholesterolemia (FH) is a condition caused by mutations in the low-density lipoprotein...
Episomal gene expression vectors offer a safe and attractive alternative to integrating vectors. Her...
Background. Gene therapy of familial hypercholesterolemia (FH) requires successful transfer and life...
Familial hypercholesterolemia (FH) is a life-threatening genetic disorder characterized by elevated ...
BACKGROUND: The delivery of a complete genomic DNA locus in vivo may prove advantageous for compleme...
Familial hypercholesterolemia (FH) is a life-threatening genetic disorder characterised by elevated ...
The generation of functional transgenes via microinjection of overlapping dna fragments has previous...
Gene therapy for hypercholesterolemia offers the potential to sustainably ameliorate disease for lif...
The recent completion of the human genome sequence allows genomics research to focus on understandin...
The development of novel strategies to enhance gene expression from therapeutic vectors may prove ad...
Familial hypercholesterolemia (FH) is a genetic hyperlipidemia characterized by elevated concentrati...
We have isolated several non-leaky mutant Chinese hamster ovary (CHO) cell clones (M4, M19, and M21)...
Acquiring sufficient amounts of high-quality cells remains an impediment to cell-based therapies. In...
We have isolated several non−leaky mutant Chinese hamster ovary (CHO) cell clones (M4, M19, and M21)...
International audienceBACKGROUND: The LDLR (low-density lipoprotein receptor) in the liver is the ma...